Literature DB >> 22237666

Bias in the reporting of family history: implications for clinical care.

Elissa M Ozanne1, Adrienne O'Connell, Colleen Bouzan, Phil Bosinoff, Taryn Rourke, Dana Dowd, Brian Drohan, Fred Millham, Pat Griffin, Elkan F Halpern, Alan Semine, Kevin S Hughes.   

Abstract

Family history of cancer is critical for identifying and managing patients at risk for cancer. However, the quality of family history data is dependent on the accuracy of patient self reporting. Therefore, the validity of family history reporting is crucial to the quality of clinical care. A retrospective review of family history data collected at a community hospital between 2005 and 2009 was performed in 43,257 women presenting for screening mammography. Reported numbers of breast, colon, prostate, lung, and ovarian cancer were compared in maternal relatives vs. paternal relatives and in first vs. second degree relatives. Significant reporting differences were found between maternal and paternal family history of cancer, in addition to degree of relative. The number of paternal family histories of cancer was significantly lower than that of maternal family histories of cancer. Similarly, the percentage of grandparents' family histories of cancer was significantly lower than the percentage of parents' family histories of cancer. This trend was found in all cancers except prostate cancer. Self-reported family history in the community setting is often influenced by both bloodline of the cancer history and the degree of relative affected. This is evident by the underreporting of paternal family histories of cancer, and also, though to a lesser extent, by degree. These discrepancies in reporting family history of cancer imply we need to take more care in collecting accurate family histories and also in the clinical management of individuals in relation to hereditary risk.

Entities:  

Mesh:

Year:  2012        PMID: 22237666     DOI: 10.1007/s10897-011-9470-x

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  30 in total

Review 1.  Reconsidering the family history in primary care.

Authors:  Eugene C Rich; Wylie Burke; Caryl J Heaton; Susanne Haga; Linda Pinsky; M Priscilla Short; Louise Acheson
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

2.  Integration of family history and medical management of patients with hereditary cancers.

Authors:  S T Tinley; H T Lynch
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

3.  Prevalence of family history of breast, colorectal, prostate, and lung cancer in a population-based study.

Authors:  P L Mai; L Wideroff; M H Greene; B I Graubard
Journal:  Public Health Genomics       Date:  2010-04-09       Impact factor: 2.000

4.  Prevalence of hereditary breast/ovarian carcinoma risk in patients with a personal history of breast or ovarian carcinoma in a mammography population.

Authors:  Francisco J Dominguez; Julie L Jones; Katherina Zabicki; Barbara L Smith; Michele A Gadd; Michele Specht; Daniel B Kopans; Richard H Moore; James S Michaelson; Kevin S Hughes
Journal:  Cancer       Date:  2005-11-01       Impact factor: 6.860

5.  Perceived cancer risk: why is it lower among nonwhites than whites?

Authors:  Heather Orom; Marc T Kiviniemi; Willie Underwood; Levi Ross; Vickie L Shavers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02-16       Impact factor: 4.254

6.  Accuracy of reporting of family history of colorectal cancer.

Authors:  R J Mitchell; D Brewster; H Campbell; M E M Porteous; A H Wyllie; C C Bird; M G Dunlop
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

7.  Genetic assessment of breast cancer risk in primary care practice.

Authors:  Wylie Burke; Julie Culver; Linda Pinsky; Sarah Hall; Susan E Reynolds; Yutaka Yasui; Nancy Press
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

8.  Family history-taking in community family practice: implications for genetic screening.

Authors:  L S Acheson; G L Wiesner; S J Zyzanski; M A Goodwin; K C Stange
Journal:  Genet Med       Date:  2000 May-Jun       Impact factor: 8.822

9.  Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention.

Authors:  Scott D Ramsey; Paula Yoon; Ramal Moonesinghe; Muin J Khoury
Journal:  Genet Med       Date:  2006-09       Impact factor: 8.822

10.  Can family history be used as a tool for public health and preventive medicine?

Authors:  Paula W Yoon; Maren T Scheuner; Kris L Peterson-Oehlke; Marta Gwinn; Andrew Faucett; Muin J Khoury
Journal:  Genet Med       Date:  2002 Jul-Aug       Impact factor: 8.822

View more
  21 in total

1.  Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men.

Authors:  Aubrey R Turner; Brian R Lane; Dan Rogers; Isaac Lipkus; Kathryn Weaver; Suzanne C Danhauer; Zheng Zhang; Fang-Chi Hsu; Sabrina L Noyes; Tamara Adams; Helga Toriello; Thomas Monroe; Trudy McKanna; Tracey Young; Ryan Rodarmer; Richard J Kahnoski; Mouafak Tourojman; A Karim Kader; S Lilly Zheng; William Baer; Jianfeng Xu
Journal:  Cancer       Date:  2016-07-19       Impact factor: 6.860

2.  Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reporters.

Authors:  Parisa Tehranifar; Hui-Chen Wu; Tom Shriver; Ann J Cloud; Mary Beth Terry
Journal:  Am J Epidemiol       Date:  2015-01-07       Impact factor: 4.897

3.  American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.

Authors:  Karen H Lu; Marie E Wood; Molly Daniels; Cathy Burke; James Ford; Noah D Kauff; Wendy Kohlmann; Noralane M Lindor; Therese M Mulvey; Linda Robinson; Wendy S Rubinstein; Elena M Stoffel; Carrie Snyder; Sapna Syngal; Janette K Merrill; Dana Swartzberg Wollins; Kevin S Hughes
Journal:  J Clin Oncol       Date:  2014-02-03       Impact factor: 44.544

4.  Cancer Incidence in First- and Second-Degree Relatives of BRCA1 and BRCA2 Mutation Carriers.

Authors:  Haley Streff; Jessica Profato; Yuanqing Ye; Denise Nebgen; Susan K Peterson; Claire Singletary; Banu K Arun; Jennifer K Litton
Journal:  Oncologist       Date:  2016-06-15

5.  Impact of family history assessment on communication with family members and health care providers: A report from the Family Healthware™ Impact Trial (FHITr).

Authors:  Catharine Wang; Ananda Sen; Melissa Plegue; Mack T Ruffin; Suzanne M O'Neill; Wendy S Rubinstein; Louise S Acheson
Journal:  Prev Med       Date:  2015-04-19       Impact factor: 4.018

Review 6.  Review and Comparison of Electronic Patient-Facing Family Health History Tools.

Authors:  Brandon M Welch; Kevin Wiley; Lance Pflieger; Rosaline Achiangia; Karen Baker; Chanita Hughes-Halbert; Heath Morrison; Joshua Schiffman; Megan Doerr
Journal:  J Genet Couns       Date:  2018-03-06       Impact factor: 2.537

7.  Factors associated with breast MRI use among women with a family history of breast cancer.

Authors:  Mary C White; Ashwini Soman; Clarice R Weinberg; Juan L Rodriguez; Susan A Sabatino; Lucy A Peipins; Lisa DeRoo; Hazel B Nichols; M Elizabeth Hodgson; Dale P Sandler
Journal:  Breast J       Date:  2018-05-20       Impact factor: 2.431

8.  Mammographic density and breast cancer risk by family history in women of white and Asian ancestry.

Authors:  Gertraud Maskarinec; Kaylae L Nakamura; Christy G Woolcott; Shannon M Conroy; Celia Byrne; Chisato Nagata; Giske Ursin; Celine M Vachon
Journal:  Cancer Causes Control       Date:  2015-03-12       Impact factor: 2.506

9.  Can we test for hereditary cancer at 18 years when we start surveillance at 25? Patient reported outcomes.

Authors:  Aisha S Sie; Judith B Prins; Liesbeth Spruijt; C Marleen Kets; Nicoline Hoogerbrugge
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

10.  Increasing colorectal cancer screening in an overdue population: participation and cost impacts of adding telephone calls to a FIT mailing program.

Authors:  Jennifer A Schlichting; Michelle A Mengeling; Nader M Makki; Ashish Malhotra; Thorvardur R Halfdanarson; J Stacey Klutts; Barcey T Levy; Peter J Kaboli; Mary E Charlton
Journal:  J Community Health       Date:  2014-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.